MAP2K7 and acute myeloid leukemia: Through a lasso linear regression analysis we assessed the potential of this data in predicting the level of sensitivity of seven AML to three kinase inhibitors: PI-103 (a PI3K/mTOR inhibitor), MEK-i, and JAK-i.